Novo Nordisk A/S (LON:0TDD)

Novo Nordisk Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 18, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	161,523	307,410	362,353	252,658	189,209	118,759
Market Cap Growth	-58.24%	-15.16%	43.42%	33.53%	59.32%	15.17%
Enterprise Value	169,571	305,424	359,902	251,287	186,765	116,186
Last Close Price	36.32	67.17	78.90	53.95	39.58	24.11
PE Ratio	13.32	27.45	37.19	38.16	35.07	23.41
PS Ratio	4.38	9.55	13.40	11.97	11.90	7.77
PB Ratio	8.13	19.32	29.21	25.38	23.68	15.58
P/TBV Ratio	21.83	85.58	67.43	65.10	60.74	23.12
P/FCF Ratio	20.95	37.56	37.45	31.75	34.42	21.39
P/OCF Ratio	11.17	22.92	28.58	26.86	30.45	18.99
EV/Sales Ratio	4.58	9.49	13.31	11.91	11.74	7.60
EV/EBITDA Ratio	8.66	18.78	27.97	25.98	25.93	16.48
EV/EBIT Ratio	9.41	19.69	29.53	27.87	27.92	17.83
EV/FCF Ratio	21.99	37.32	37.20	31.57	33.97	20.93
Debt / Equity Ratio	0.60	0.72	0.25	0.31	0.38	0.16
Debt / EBITDA Ratio	0.61	0.69	0.24	0.31	0.41	0.17
Debt / FCF Ratio	1.53	1.39	0.33	0.39	0.55	0.23
Asset Turnover	0.69	0.74	0.84	0.81	0.83	0.94
Inventory Turnover	1.22	1.20	1.26	1.29	1.24	1.16
Quick Ratio	0.53	0.52	0.62	0.67	0.65	0.64
Current Ratio	0.78	0.74	0.82	0.90	0.86	0.94
Return on Equity (ROE)	71.47%	80.77%	88.07%	72.00%	71.24%	69.70%
Return on Assets (ROA)	21.11%	22.41%	23.55%	21.69%	21.81%	25.01%
Return on Capital (ROIC)	42.81%	46.03%	53.89%	45.74%	43.27%	49.84%
Return on Capital Employed (ROCE)	55.30%	56.30%	72.30%	62.80%	62.30%	72.50%
Earnings Yield	7.51%	3.64%	2.69%	2.62%	2.85%	4.27%
FCF Yield	4.77%	2.66%	2.67%	3.15%	2.90%	4.67%
Dividend Yield	1.93%	1.88%	1.39%	1.37%	1.48%	2.27%
Payout Ratio	49.88%	43.71%	37.96%	45.57%	45.05%	47.75%
Buyback Yield / Dilution	0.46%	0.71%	1.10%	1.34%	1.58%	1.63%
Total Shareholder Return	2.39%	2.59%	2.48%	2.71%	3.06%	3.90%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.